Skip to main content

New developments in the management of COPD

New developments in the management of COPD

Session Date:

Associate Professor Rob Young discusses the diagnosis of COPD and simplifying treatment in the New Zealand context.

He will cover the pharmacological guideline pathways, the benefits of triple & dual therapy on COPD, & non-pharmacological management.

BIO: Rob Young


Associate Professor Young is a Consultant Physician in the Department of Medicine, Auckland City Hospital and Associate Professor in the Faculty of Medical and Health Sciences at the University of Auckland. Currently, he lectures to medical students and post-graduate science students.

His research and clinical interests focus on the primary prevention and early diagnosis of smoking-related respiratory diseases COPD and lung cancer. He has been the first to show that COPD and lung cancer are linked at a molecular genetic level through overlapping pathogenetic pathways that are activated by smoking in susceptible smokers.


This breakfast presentation is supported by: